Status:
UNKNOWN
Hydroxy Chloroquine and Covid in RA Patients
Lead Sponsor:
Tanta University
Conditions:
COVID
Eligibility:
All Genders
18+ years
Brief Summary
evaluation of the clinical course of COVID-19 in a cohort of patients with rheumatoid arthritis treated with or without hydroxychloroquine.
Detailed Description
Study settings \& sample: This is an observational, retrospective -case-control, single-center study. This study will include patients who meet the inclusion criteria followed in the Department of Rh...
Eligibility Criteria
Inclusion
- Adult patients with rheumatoid arthritis superinfected with Covid-19
Exclusion
- Insufficient data are available in the medical record.
Key Trial Info
Start Date :
June 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04471649
Start Date
June 15 2020
End Date
November 1 2020
Last Update
September 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University Hospital
Tanta, Egypt, 31527